Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine.
Browsing: Research > Clinical
Rapid detection and identification of pathogens is crucial to combat biothreat agents. Here, we take a look at some of the emerging technologies and how they could be used to diagnose disease for civilian biodefense.
In this editorial, the authors assess the insights that could be provided by PET imaging in evaluating and understanding the progression of neurological sequale in Zika virus.
We take a look at the key microbiome therapeutics currently in the clinical pipeline for recurrent C. difficile infections and their prospects for the treatment of this disease in the future.
A Phase II trial has suggested potential for new Bacille Calmette–Guerin revaccination strategies in addition to hope for subunit vaccines against tuberculosis.
Listen to our podcast rounding up the top news stories of the week, including the measles vaccine and the sexual transmission of Zika.
A new study has revealed that a promising antioxidant drug could prevent sexual transmission of the Zika virus, offering a potential role for the drug in preventing spread among humans.
In our latest infographic we provide a visual snapshot of the infections and immune processes that have been linked with the microbiome thus far, explaining some of the evidence
In this article, the authors test ocellatin peptides against one of the most concerning priority pathogens, Pseudomonas aeruginosa.